Hypophosphatasia Treatment Market Outlook: Strensiq Costs,...

adicionou um novo artigo Health

2026-08-12 05:17:20 -

Hypophosphatasia Treatment Market Outlook: Strensiq Costs, Therapeutic Advances, and Future Opportunities

Hypophosphatasia Treatment Market Overview Hypophosphatasia is an ultra-rare inherited metabolic disorder caused by pathogenic changes in the ALPL gene, leading to deficient tissue-nonspecific alkaline phosphatase activity. The condition disrupts bone and dental mineralization and can range from severe perinatal manifestations to comparatively mild adult-onset disease. DelveInsight estimated...

0 Comentários 0 Compartilhamentos 10 Visualizações 0 Anterior